{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:15:46Z","timestamp":1785273346197,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Kids Cancer Care Foundation of Alberta","award":["10024168"],"award-info":[{"award-number":["10024168"]}]},{"name":"Kids Cancer Care Foundation of Alberta","award":["10024168"],"award-info":[{"award-number":["10024168"]}]},{"name":"Kids Cancer Care Foundation of Alberta","award":["10024168"],"award-info":[{"award-number":["10024168"]}]},{"name":"Kids Cancer Care Foundation of Alberta","award":["10024168"],"award-info":[{"award-number":["10024168"]}]},{"name":"Rein in Sarcoma","award":["10044714"],"award-info":[{"award-number":["10044714"]}]},{"name":"Rein in Sarcoma","award":["10044714"],"award-info":[{"award-number":["10044714"]}]},{"name":"Rein in Sarcoma","award":["10044714"],"award-info":[{"award-number":["10044714"]}]},{"name":"Rein in Sarcoma","award":["10044714"],"award-info":[{"award-number":["10044714"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20994-8","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:45:01Z","timestamp":1761219901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer-associated fibroblasts promote tumor progression in fusion-positive rhabdomyosarcoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Patrick","family":"Sipila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Son","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Langevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aru","family":"Narendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"20994_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1615\/CritRevOncog.2015013800","volume":"20","author":"JF Shern","year":"2015","unstructured":"Shern, J. F., Yohe, M. E. & Khan, J. Pediatric rhabdomyosarcoma. Crit. Rev. Oncog. 20, 227\u2013243 (2015).","journal-title":"Crit. Rev. Oncog."},{"key":"20994_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/ng1193-230","volume":"5","author":"N Galili","year":"1993","unstructured":"Galili, N. et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5, 230\u2013235 (1993).","journal-title":"Nat. Genet."},{"key":"20994_CR3","first-page":"2869","volume":"54","author":"RJ Davis","year":"1994","unstructured":"Davis, R. J., D\u2019Cruz, C. M., Lovell, M. A., Biegel, J. A. & Barr, F. G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54, 2869\u20132872 (1994).","journal-title":"Cancer Res."},{"key":"20994_CR4","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.3390\/cancers15215269","volume":"15","author":"A Zarrabi","year":"2023","unstructured":"Zarrabi, A. et al. Rhabdomyosarcoma: Current therapy, challenges, and future approaches to treatment strategies. Cancers. 15, 5269 (2023).","journal-title":"Cancers"},{"key":"20994_CR5","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1158\/1078-0432.CCR-19-3416","volume":"26","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. The immunosuppressive niche of soft-tissue sarcomas is sustained by tumor-associated macrophages and characterized by intratumoral tertiary lymphoid structures. Clin. Cancer Res. 26, 4018\u20134030 (2020).","journal-title":"Clin. Cancer Res."},{"key":"20994_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13569-016-0064-0","volume":"6","author":"L Paoluzzi","year":"2016","unstructured":"Paoluzzi, L. et al. Response to anti-PD1 therapy with nivolumab in metastatic sarcomas. Clin. Sarcoma Res. 6, 24 (2016).","journal-title":"Clin. Sarcoma Res."},{"key":"20994_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"key":"20994_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer. 16, 582\u2013598 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"20994_CR9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang, D., Liu, J., Qian, H. & Zhuang, Q. Cancer-associated fibroblasts: From basic science to anticancer therapy. Exp. Mol. Med. 55, 1322\u20131332 (2023).","journal-title":"Exp. Mol. Med."},{"key":"20994_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fonc.2020.00076","volume":"10","author":"M Saggioro","year":"2020","unstructured":"Saggioro, M., D\u2019Angelo, E., Bisogno, G., Agostini, M. & Pozzobon, M. Carcinoma and sarcoma microenvironment at a glance: Where we are. Front. Oncol. 10, 76 (2020).","journal-title":"Front. Oncol."},{"key":"20994_CR11","first-page":"1222","volume":"11","author":"Y Hachitanda","year":"1998","unstructured":"Hachitanda, Y., Toyoshima, S., Akazawa, K. & Tsuneyoshi, M. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: Its correlation with histologic features. Mod. Pathol. Off J. United States Can. Acad. Pathol. Inc. 11, 1222\u20131227 (1998).","journal-title":"Mod. Pathol. : Off J. United States Can. Acad. Pathol. Inc"},{"key":"20994_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40364-020-00245-w","volume":"8","author":"C Han","year":"2020","unstructured":"Han, C., Liu, T. & Yin, R. Biomarkers for cancer-associated fibroblasts. Biomark. Res. 8, 64 (2020).","journal-title":"Biomark. Res."},{"issue":"SUPPL","key":"20994_CR13","first-page":"387","volume":"88","author":"LA Hayflick","year":"1963","unstructured":"Hayflick, L. A. Comparison of primary monkey kidney, heteroploid cell lines, and human diploid cell strains for human virus vaccine Preparation1,2. Am Rev. Respir Dis. 88 (SUPPL), 387\u2009\u2013393  (1963).","journal-title":"Am Rev. Respir Dis."},{"key":"20994_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/gcc.2870120305","volume":"12","author":"JA Biegel","year":"1995","unstructured":"Biegel, J. A., Nycum, L. M., Valentine, V., Barr, F. G. & Shapiro, D. N. Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization. Genes Chromosom Cancer. 12, 186\u2013192 (1995).","journal-title":"Genes Chromosom Cancer"},{"key":"20994_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000132446","volume":"45","author":"EC Douglass","year":"1987","unstructured":"Douglass, E. C. et al. A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet. Genome Res. 45, 148\u2013155 (1987).","journal-title":"Cytogenet. Genome Res."},{"key":"20994_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fonc.2013.00183","volume":"3","author":"ARP Hinson","year":"2013","unstructured":"Hinson, A. R. P. et al. Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: Utility and pitfalls. Front. Oncol. 3, 183 (2013).","journal-title":"Front. Oncol."},{"key":"20994_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M","volume":"24","author":"RM McAllister","year":"1969","unstructured":"McAllister, R. M., Melnyk, J., Finklestein, J. Z., Adams, E. C. & Gardner, M. B. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 24, 520\u2013526 (1969).","journal-title":"Cancer"},{"key":"20994_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang, C. C., Park, A. Y. & Guan, J. L. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2, 329\u2013333 (2007).","journal-title":"Nat. Protoc."},{"key":"20994_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/cancers13050987","volume":"13","author":"A Domen","year":"2021","unstructured":"Domen, A. et al. Cancer-associated fibroblasts as a common orchestrator of therapy resistance in lung and pancreatic cancer. Cancers. 13, 987 (2021).","journal-title":"Cancers"},{"key":"20994_CR20","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/cancers12071758","volume":"12","author":"S Miwa","year":"2020","unstructured":"Miwa, S. et al. Recent advances and challenges in the treatment of rhabdomyosarcoma. Cancers. 12, 1758 (2020).","journal-title":"Cancers"},{"key":"20994_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13046-020-01756-y","volume":"39","author":"JF Liu","year":"2020","unstructured":"Liu, J. F., Chen, P. C., Chang, T. M. & Hou, C. H. Monocyte chemoattractant Protein-1 promotes cancer cell migration via c-Raf\/MAPK\/AP-1 pathway and MMP-9 production in osteosarcoma. J. Exp. Clin. Cancer Res. 39, 254 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"20994_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/cas.14752","volume":"112","author":"G Zhang","year":"2021","unstructured":"Zhang, G. et al. Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. Cancer Sci. 112, 997\u20131010 (2021).","journal-title":"Cancer Sci."},{"key":"20994_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13058-023-01684-7","volume":"25","author":"N Chuangchot","year":"2023","unstructured":"Chuangchot, N. et al. Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3\/AKT pathways. Breast Cancer Res. 25, 86 (2023).","journal-title":"Breast Cancer Res."},{"key":"20994_CR24","first-page":"1844","volume":"19","author":"F Li","year":"2020","unstructured":"Li, F., Xu, X., Geng, J., Wan, X. & Dai, H. The autocrine CXCR4\/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity. Exp. Ther. Med. 19, 1844\u20131854 (2020).","journal-title":"Exp. Ther. Med."},{"key":"20994_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12931-020-01467-0","volume":"21","author":"J Jaffar","year":"2020","unstructured":"Jaffar, J. et al. CXCR4\u2009+\u2009cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis. Respir Res. 21, 221 (2020).","journal-title":"Respir Res."},{"key":"20994_CR26","first-page":"1009","volume":"126","author":"QE Yang","year":"2012","unstructured":"Yang, Q. E., Kim, D., Kaucher, A., Oatley, M. J. & Oatley, J. M. CXCL12\u2013CXCR4 signaling is required for the maintenance of mouse spermatogonial stem cells. J. Cell. Sci. 126, 1009\u20131020 (2012).","journal-title":"J. Cell. Sci."},{"key":"20994_CR27","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.4049\/jimmunol.160.9.4153","volume":"160","author":"P Jourdan","year":"1998","unstructured":"Jourdan, P. et al. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J. Immunol. (Baltim., Md: 1950).  160, 4153\u20134157 (1998).","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"key":"20994_CR28","doi-asserted-by":"publisher","first-page":"H563","DOI":"10.1152\/ajpheart.00603.2017","volume":"315","author":"JM Bradley","year":"2018","unstructured":"Bradley, J. M. et al. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure. Am. J. Physiol. Heart Circ. Physiol. 315, H563\u2013H570 (2018).","journal-title":"Am. J. Physiol. -Hear Circ. Physiol."},{"key":"20994_CR29","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1073\/pnas.84.3.842","volume":"84","author":"L Schweigerer","year":"1987","unstructured":"Schweigerer, L. et al. Basic fibroblast growth factor in human rhabdomyosarcoma cells: Implications for the proliferation and neovascularization of myoblast-derived tumors. Proc. Natl. Acad. Sci. 84, 842\u2013846 (1987).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"20994_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1096\/fasebj.14.9.1147","volume":"14","author":"M Bouch\u00e9","year":"2000","unstructured":"Bouch\u00e9, M. et al. TGF-\u03b2 autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cells. FASEB J. 14, 1147\u20131158 (2000).","journal-title":"FASEB J."},{"key":"20994_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41389-021-00302-5","volume":"10","author":"H Yoon","year":"2021","unstructured":"Yoon, H. et al. TGF-\u03b21-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in Gastrointestinal stromal tumor. Oncogenesis. 10, 13 (2021).","journal-title":"Oncogenesis"},{"key":"20994_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3892\/ijo.2015.3060","volume":"47","author":"S Wen","year":"2015","unstructured":"Wen, S., Niu, Y., Yeh, S. & Chang, C. BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts. Int. J. Oncol. 47, 719\u2013727 (2015).","journal-title":"Int. J. Oncol."},{"key":"20994_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell. 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"20994_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov"},{"key":"20994_CR35","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1038\/onc.2008.255","volume":"27","author":"E Taniguchi","year":"2008","unstructured":"Taniguchi, E. et al. PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma. Oncogene. 27, 6550\u20136560 (2008).","journal-title":"Oncogene"},{"key":"20994_CR36","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1158\/0008-5472.CAN-06-1021","volume":"67","author":"M Wysoczynski","year":"2007","unstructured":"Wysoczynski, M. et al. Leukemia inhibitory factor: A newly identified metastatic factor in rhabdomyosarcomas. Cancer Res. 67, 2131\u20132140 (2007).","journal-title":"Cancer Res."},{"key":"20994_CR37","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura, T., Li, C., Wang, Y. & Matsukawa, A. The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell. Mol. Immunol. 20, 714\u2013738 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"20994_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00262-025-04051-x","volume":"74","author":"H Kondo","year":"2025","unstructured":"Kondo, H. et al. Osteosarcoma cell\u2013derived CCL2 facilitates lung metastasis via accumulation of tumor-associated macrophages. Cancer Immunol. Immunother. 74, 193 (2025).","journal-title":"Cancer Immunol. Immunother"},{"key":"20994_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0344-0338(86)80003-6","volume":"181","author":"SM Monte","year":"1986","unstructured":"Monte, S. M., de la, Hutchins, G. M. & Moore, G. W. Metastatic behavior of rhabdomyosarcoma. Pathol. Res. Pract. 181, 148\u2013152 (1986).","journal-title":"Pathol. - Res. Pr"},{"key":"20994_CR40","doi-asserted-by":"publisher","first-page":"8025","DOI":"10.1038\/sj.onc.1208939","volume":"24","author":"MFW Gee","year":"2005","unstructured":"Gee, M. F. W. et al. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Oncogene. 24, 8025\u20138037 (2005).","journal-title":"Oncogene"},{"key":"20994_CR41","first-page":"791","volume":"27","author":"M Onisto","year":"2005","unstructured":"Onisto, M. et al. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Int. J. Oncol. 27, 791\u2013798 (2005).","journal-title":"Int. J. Oncol."},{"key":"20994_CR42","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/ijc.32278","volume":"145","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Cancer-associated fibroblasts promote PD\u2010L1 expression in mice cancer cells via secreting CXCL5. Int. J. Cancer. 145, 1946\u20131957 (2019).","journal-title":"Int. J. Cancer"},{"key":"20994_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13046-024-03122-8","volume":"43","author":"D Sun","year":"2024","unstructured":"Sun, D. et al. CXCL5 impedes CD8\u2009+\u2009T cell immunity by upregulating PD-L1 expression in lung cancer via PXN\/AKT signaling phosphorylation and neutrophil chemotaxis. J. Exp. Clin. Cancer Res. 43, 202 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"20994_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nm.1908","volume":"15","author":"P Farmer","year":"2009","unstructured":"Farmer, P. et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat. Med. 15, 68\u201374 (2009).","journal-title":"Nat. Med."},{"key":"20994_CR45","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-021-23923-1","volume":"12","author":"F Hu","year":"2021","unstructured":"Hu, F. et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nat. Commun. 12, 3651 (2021).","journal-title":"Nat. Commun."},{"key":"20994_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2174\/1568009615666150916093110","volume":"16","author":"X Wu","year":"2016","unstructured":"Wu, X. et al. Persistent GP130\/STAT3 signaling contributes to the resistance of doxorubicin, cisplatin, and MEK inhibitor in human rhabdomyosarcoma cells. Curr. Cancer Drug Targets. 16, 631\u2013638 (2016).","journal-title":"Curr. Cancer Drug Targets"},{"key":"20994_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2407-7-111","volume":"7","author":"CL Chen","year":"2007","unstructured":"Chen, C. L. et al. Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMC Cancer. 7, 111 (2007).","journal-title":"BMC Cancer"},{"key":"20994_CR48","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbrc.2011.03.014","volume":"407","author":"S Reed","year":"2011","unstructured":"Reed, S., Li, H., Li, C. & Lin, J. Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells. Biochem. Biophys. Res. Commun. 407, 450\u2013455 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20994_CR49","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/j.1349-7006.2011.01932.x","volume":"102","author":"A Liu","year":"2011","unstructured":"Liu, A. et al. Novel small molecule, XZH-5, inhibits constitutive and interleukin\u20106\u2010induced STAT3 phosphorylation in human rhabdomyosarcoma cells. Cancer Sci. 102, 1381\u20131387 (2011).","journal-title":"Cancer Sci."},{"key":"20994_CR50","doi-asserted-by":"publisher","first-page":"e0180297","DOI":"10.1371\/journal.pone.0180297","volume":"12","author":"H Xiao","year":"2017","unstructured":"Xiao, H. et al. Repositioning bazedoxifene as a novel IL-6\/GP130 signaling antagonist for human rhabdomyosarcoma therapy. PLoS ONE. 12, e0180297 (2017).","journal-title":"PLoS ONE"},{"key":"20994_CR51","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/9511","volume":"5","author":"T Sethi","year":"1999","unstructured":"Sethi, T. et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 5, 662\u2013668 (1999).","journal-title":"Nat. Med."},{"key":"20994_CR52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41419-021-03509-x","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4\/\u03b2-catenin\/PPAR\u03b4 signalling. Cell. Death Dis. 12, 214 (2021).","journal-title":"Cell. Death Dis."},{"key":"20994_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell. 121, 335\u2013348 (2005).","journal-title":"Cell"},{"key":"20994_CR54","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/cas.12490","volume":"105","author":"K Kashima","year":"2014","unstructured":"Kashima, K. et al. Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4. Cancer Sci. 105, 1343\u20131350 (2014).","journal-title":"Cancer Sci."},{"key":"20994_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3892\/ijo.2020.5059","volume":"57","author":"S Regenbogen","year":"2020","unstructured":"Regenbogen, S. et al. Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma. Int. J. Oncol. 57, 289\u2013300 (2020).","journal-title":"Int. J. Oncol."},{"key":"20994_CR56","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1158\/1078-0432.CCR-07-4446","volume":"14","author":"F Diomedi-Camassei","year":"2008","unstructured":"Diomedi-Camassei, F. et al. Clinical significance of CXC chemokine Receptor-4 and c-Met in childhood rhabdomyosarcoma. Clin. Cancer Res. 14, 4119\u20134127 (2008).","journal-title":"Clin. Cancer Res."},{"key":"20994_CR57","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1158\/1541-7786.MCR-10-0288","volume":"8","author":"M Tarnowski","year":"2010","unstructured":"Tarnowski, M. et al. Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. Mol. Cancer Res. 8, 1328\u20131343 (2010).","journal-title":"Mol. Cancer Res."},{"key":"20994_CR58","doi-asserted-by":"publisher","first-page":"600980","DOI":"10.3389\/fonc.2020.600980","volume":"10","author":"S D\u2019Agostino","year":"2021","unstructured":"D\u2019Agostino, S. et al. Rhabdomyosarcoma cells produce their own extracellular matrix with minimal involvement of cancer-associated fibroblasts: A preliminary study. Front. Oncol. 10, 600980 (2021).","journal-title":"Front. Oncol."},{"key":"20994_CR59","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods. 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"20994_CR60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinform. 18, 529 (2017).","journal-title":"BMC Bioinform"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20994-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20994-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20994-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:03:41Z","timestamp":1761224621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20994-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20994"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20994-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37118"}}